PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens

Christian Massire, Daelynn R. Buelow, Sean Xiang Zhang, Robert Lovari, Heather E. Matthews, Donna M. Toleno, Raymond R. Ranken, Thomas A. Hall, David Metzgar, Rangarajan Sampath, Lawrence B. Blyn, David J. Ecker, Zhengming Gu, Thomas J. Walsh, Randall T. Hayden

Research output: Contribution to journalArticle

Abstract

Invasive fungal infections are a significant cause of morbidity and mortality among immunocompromised patients. Early and accurate identification of these pathogens is central to direct therapy and to improve overall outcome. PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) was evaluated as a novel means for identification of fungal pathogens. Using a database grounded by 60 ATCC reference strains, a total of 394 clinical fungal isolates (264 molds and 130 yeasts) were analyzed by PCR/ESI-MS; results were compared to phenotypic identification, and discrepant results were sequence confirmed. PCR/ESI-MS identified 81.4% of molds to either the genus or species level, with concordance rates of 89.7% and 87.4%, respectively, to phenotypic identification. Likewise, PCR/ESI-MS was able to identify 98.4% of yeasts to either the genus or species level, agreeing with 100% of phenotypic results at both the genus and species level. PCR/ESI-MS performed best with Aspergillus and Candida isolates, generating species-level identification in 94.4% and 99.2% of isolates, respectively. PCR/ESI-MS is a promising new technology for broad-range detection and identification of medically important fungal pathogens that cause invasive mycoses.

Original languageEnglish (US)
Pages (from-to)959-966
Number of pages8
JournalJournal of Clinical Microbiology
Volume51
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Electrospray Ionization Mass Spectrometry
Polymerase Chain Reaction
Fungi
Yeasts
Immunocompromised Host
Aspergillus
Candida
Databases
Technology
Morbidity
Mortality

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. / Massire, Christian; Buelow, Daelynn R.; Zhang, Sean Xiang; Lovari, Robert; Matthews, Heather E.; Toleno, Donna M.; Ranken, Raymond R.; Hall, Thomas A.; Metzgar, David; Sampath, Rangarajan; Blyn, Lawrence B.; Ecker, David J.; Gu, Zhengming; Walsh, Thomas J.; Hayden, Randall T.

In: Journal of Clinical Microbiology, Vol. 51, No. 3, 03.2013, p. 959-966.

Research output: Contribution to journalArticle

Massire, C, Buelow, DR, Zhang, SX, Lovari, R, Matthews, HE, Toleno, DM, Ranken, RR, Hall, TA, Metzgar, D, Sampath, R, Blyn, LB, Ecker, DJ, Gu, Z, Walsh, TJ & Hayden, RT 2013, 'PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens', Journal of Clinical Microbiology, vol. 51, no. 3, pp. 959-966. https://doi.org/10.1128/JCM.02621-12
Massire, Christian ; Buelow, Daelynn R. ; Zhang, Sean Xiang ; Lovari, Robert ; Matthews, Heather E. ; Toleno, Donna M. ; Ranken, Raymond R. ; Hall, Thomas A. ; Metzgar, David ; Sampath, Rangarajan ; Blyn, Lawrence B. ; Ecker, David J. ; Gu, Zhengming ; Walsh, Thomas J. ; Hayden, Randall T. / PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. In: Journal of Clinical Microbiology. 2013 ; Vol. 51, No. 3. pp. 959-966.
@article{c1fecc700f0e4bcc8272c09adb2ac44f,
title = "PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens",
abstract = "Invasive fungal infections are a significant cause of morbidity and mortality among immunocompromised patients. Early and accurate identification of these pathogens is central to direct therapy and to improve overall outcome. PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) was evaluated as a novel means for identification of fungal pathogens. Using a database grounded by 60 ATCC reference strains, a total of 394 clinical fungal isolates (264 molds and 130 yeasts) were analyzed by PCR/ESI-MS; results were compared to phenotypic identification, and discrepant results were sequence confirmed. PCR/ESI-MS identified 81.4{\%} of molds to either the genus or species level, with concordance rates of 89.7{\%} and 87.4{\%}, respectively, to phenotypic identification. Likewise, PCR/ESI-MS was able to identify 98.4{\%} of yeasts to either the genus or species level, agreeing with 100{\%} of phenotypic results at both the genus and species level. PCR/ESI-MS performed best with Aspergillus and Candida isolates, generating species-level identification in 94.4{\%} and 99.2{\%} of isolates, respectively. PCR/ESI-MS is a promising new technology for broad-range detection and identification of medically important fungal pathogens that cause invasive mycoses.",
author = "Christian Massire and Buelow, {Daelynn R.} and Zhang, {Sean Xiang} and Robert Lovari and Matthews, {Heather E.} and Toleno, {Donna M.} and Ranken, {Raymond R.} and Hall, {Thomas A.} and David Metzgar and Rangarajan Sampath and Blyn, {Lawrence B.} and Ecker, {David J.} and Zhengming Gu and Walsh, {Thomas J.} and Hayden, {Randall T.}",
year = "2013",
month = "3",
doi = "10.1128/JCM.02621-12",
language = "English (US)",
volume = "51",
pages = "959--966",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens

AU - Massire, Christian

AU - Buelow, Daelynn R.

AU - Zhang, Sean Xiang

AU - Lovari, Robert

AU - Matthews, Heather E.

AU - Toleno, Donna M.

AU - Ranken, Raymond R.

AU - Hall, Thomas A.

AU - Metzgar, David

AU - Sampath, Rangarajan

AU - Blyn, Lawrence B.

AU - Ecker, David J.

AU - Gu, Zhengming

AU - Walsh, Thomas J.

AU - Hayden, Randall T.

PY - 2013/3

Y1 - 2013/3

N2 - Invasive fungal infections are a significant cause of morbidity and mortality among immunocompromised patients. Early and accurate identification of these pathogens is central to direct therapy and to improve overall outcome. PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) was evaluated as a novel means for identification of fungal pathogens. Using a database grounded by 60 ATCC reference strains, a total of 394 clinical fungal isolates (264 molds and 130 yeasts) were analyzed by PCR/ESI-MS; results were compared to phenotypic identification, and discrepant results were sequence confirmed. PCR/ESI-MS identified 81.4% of molds to either the genus or species level, with concordance rates of 89.7% and 87.4%, respectively, to phenotypic identification. Likewise, PCR/ESI-MS was able to identify 98.4% of yeasts to either the genus or species level, agreeing with 100% of phenotypic results at both the genus and species level. PCR/ESI-MS performed best with Aspergillus and Candida isolates, generating species-level identification in 94.4% and 99.2% of isolates, respectively. PCR/ESI-MS is a promising new technology for broad-range detection and identification of medically important fungal pathogens that cause invasive mycoses.

AB - Invasive fungal infections are a significant cause of morbidity and mortality among immunocompromised patients. Early and accurate identification of these pathogens is central to direct therapy and to improve overall outcome. PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) was evaluated as a novel means for identification of fungal pathogens. Using a database grounded by 60 ATCC reference strains, a total of 394 clinical fungal isolates (264 molds and 130 yeasts) were analyzed by PCR/ESI-MS; results were compared to phenotypic identification, and discrepant results were sequence confirmed. PCR/ESI-MS identified 81.4% of molds to either the genus or species level, with concordance rates of 89.7% and 87.4%, respectively, to phenotypic identification. Likewise, PCR/ESI-MS was able to identify 98.4% of yeasts to either the genus or species level, agreeing with 100% of phenotypic results at both the genus and species level. PCR/ESI-MS performed best with Aspergillus and Candida isolates, generating species-level identification in 94.4% and 99.2% of isolates, respectively. PCR/ESI-MS is a promising new technology for broad-range detection and identification of medically important fungal pathogens that cause invasive mycoses.

UR - http://www.scopus.com/inward/record.url?scp=84874067161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874067161&partnerID=8YFLogxK

U2 - 10.1128/JCM.02621-12

DO - 10.1128/JCM.02621-12

M3 - Article

C2 - 23303501

AN - SCOPUS:84874067161

VL - 51

SP - 959

EP - 966

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 3

ER -